1. Search Result
Search Result
Results for "

GLS2

" in MedChemExpress (MCE) Product Catalog:

12

Inhibitors & Agonists

3

Antibodies

3

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-12248
    Telaglenastat
    100+ Cited Publications

    CB-839

    Glutaminase Autophagy Cancer
    Telaglenastat (CB-839) is a first-in-class, selective, reversible and orally active glutaminase 1 (GLS1) inhibitor. Telaglenastat selectively inhibits GLS1 splice variants KGA (kidney-type glutaminase) and GAC (glutaminase C) compared to GLS2. The IC50s are 23 nM and 28 nM for endogenous glutaminase in mouse kidney and brain, respectively. Telaglenastat inuduces autophagy and has antitumor activity .
    Telaglenastat
  • HY-103671

    Glutaminase Inflammation/Immunology Cancer
    IPN-60090 is an orally active and highly selective inhibitor of glutaminase 1 (GLS1; IC50=31 nM), with no activity observed against GLS-2. IPN-60090 exhibits excellent physicochemical and pharmacokinetic properties in vivo. IPN-60090 can be used for solid tumors research, such as lung and ovarian cancers [2].
    IPN60090
  • HY-103671A

    Glutaminase Inflammation/Immunology Cancer
    IPN-60090 dihydrochloride is an orally active and highly selective inhibitor of glutaminase 1 (GLS1; IC50=31 nM), with no activity observed against GLS-2. IPN-60090 dihydrochloride exhibits excellent physicochemical and pharmacokinetic properties in vivo. IPN-60090 dihydrochloride can be used for solid tumors research, such as lung and ovarian cancers [2].
    IPN60090 dihydrochloride
  • HY-P2760

    GLS

    Biochemical Assay Reagents Glutaminase Cancer
    Glutaminase is a metabolic enzyme. Glutaminase catalyzes the hydrolysis of glutamine to glutamate. Glutaminase isoenzymes are encoded by Gls and Gls2 genes. Proteins GLS and GLS2 have different kinetic, immunologic, and molecular characteristics. Glutaminase can be used in the research of cancer [2].
    Glutaminase
  • HY-12248R

    CB-839 (Standard)

    Glutaminase Autophagy Reference Standards Cancer
    Telaglenastat (Standard) is the analytical standard of Telaglenastat. This product is intended for research and analytical applications. Telaglenastat (CB-839) is a first-in-class, selective, reversible and orally active glutaminase 1 (GLS1) inhibitor. Telaglenastat selectively inhibits GLS1 splice variants KGA (kidney-type glutaminase) and GAC (glutaminase C) compared to GLS2. The IC50s are 23 nM and 28 nM for endogenous glutaminase in mouse kidney and brain, respectively. Telaglenastat inuduces autophagy and has antitumor activity .
    Telaglenastat (Standard)
  • HY-RS05503

    Small Interfering RNA (siRNA) Others

    GLS2 Human Pre-designed siRNA Set A contains three designed siRNAs for GLS2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    GLS2 Human Pre-designed siRNA Set A
    GLS2 Human Pre-designed siRNA Set A
  • HY-RS24276

    Small Interfering RNA (siRNA) Others

    Gls2 Rat Pre-designed siRNA Set A contains three designed siRNAs for Gls2 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Gls2 Rat Pre-designed siRNA Set A
    Gls2 Rat Pre-designed siRNA Set A
  • HY-RS17808

    Small Interfering RNA (siRNA) Others

    Gls2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Gls2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Gls2 Mouse Pre-designed siRNA Set A
    Gls2 Mouse Pre-designed siRNA Set A
  • HY-151434

    Glutaminase Apoptosis Cancer
    GLS1 Inhibitor-6 (Compound 24y) is an orally active, potent and selective glutaminase 1 (GLS1) inhibitor (IC50=68 nM), shows 220-fold selectivity for GLS2. GLS1 Inhibitor-6 shows good anti-tumor activity, antitumor cell proliferation activity and induces apoptosis .
    GLS1 Inhibitor-6
  • HY-12248A

    CB-839 hydrochloride

    Glutaminase Autophagy Cancer
    Telaglenastat (CB-839) hydrochloride is a first-in-class, selective, reversible and orally active glutaminase 1 (GLS1) inhibitor. Telaglenastat hydrochloride selectively inhibits GLS1 splice variants KGA (kidney-type glutaminase) and GAC (glutaminase C) compared to GLS2. The IC50s are 23 nM and 28 nM for endogenous glutaminase in mouse kidney and brain, respectively. Telaglenastat hydrochloride inudces autophagy and has antitumor activity .
    Telaglenastat hydrochloride
  • HY-103671AR

    Reference Standards Glutaminase Inflammation/Immunology Cancer
    IPN60090 dihydrochloride (Standard) is the analytical standard of IPN60090 dihydrochloride (HY-103671A). This product is intended for research and analytical applications. IPN-60090 dihydrochloride is an orally active and highly selective inhibitor of glutaminase 1 (GLS1; IC50=31 nM), with no activity observed against GLS-2. IPN-60090 dihydrochloride exhibits excellent physicochemical and pharmacokinetic properties in vivo. IPN-60090 dihydrochloride can be used for solid tumors research, such as lung and ovarian cancers [2].
    IPN60090 dihydrochloride (Standard)
  • HY-103671R

    Reference Standards Glutaminase Inflammation/Immunology Cancer
    IPN60090 (Standard) is the analytical standard of IPN60090 (HY-103671). This product is intended for research and analytical applications. IPN-60090 is an orally active and highly selective inhibitor of glutaminase 1 (GLS1; IC50=31 nM), with no activity observed against GLS-2. IPN-60090 exhibits excellent physicochemical and pharmacokinetic properties in vivo. IPN-60090 can be used for solid tumors research, such as lung and ovarian cancers [2].
    IPN60090 (Standard)

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: